Treatment-Resistant Depression Clinical Trial
Official title:
PINS Stimulator System for Patients With Treatment Resistant Depression
Evaluate the effects and safety of Deep Brain Stimulation (DBS) to treat on patients with Treatment-Resistant Depression (TRD) and using functional magnetic resonance imaging (fMRI)to evaluate the influence of acupuncture on patients, which will be afford objective evidence for the mechanism of Acupuncture on depression.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02497287 -
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
|
Phase 3 | |
Recruiting |
NCT03653858 -
Efficacy Study of Deep Brain Stimulation in Patients With Treatment Resistant Major Depression
|
N/A | |
Recruiting |
NCT01868802 -
Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population
|
Phase 2 | |
Recruiting |
NCT02462551 -
Focal Electrically Administered Seizure Therapy for the Treatment of Depression
|
N/A | |
Recruiting |
NCT05377177 -
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
|
N/A | |
Completed |
NCT05095792 -
Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)
|
||
Recruiting |
NCT06372834 -
Adjuvant Accelerated piTBS for Reducing Suicidal Ideation in TRD Patients
|
N/A | |
Active, not recruiting |
NCT03701724 -
Cost-utility Analysis of Maintenance rTMS for Treatment-resistant Depression
|
N/A | |
Recruiting |
NCT05800860 -
A Trial of GH001 in Patients With Treatment-resistant Depression
|
Phase 2 | |
Not yet recruiting |
NCT06404320 -
Physical Activity Program for TRD
|
N/A | |
Completed |
NCT01945047 -
Action of Ketamine in Treatment-Resistant Depression
|
Phase 2/Phase 3 | |
Recruiting |
NCT05045378 -
Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression
|
Phase 4 | |
Completed |
NCT05454410 -
Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)
|
Phase 2 | |
Recruiting |
NCT05422417 -
Dorsomedial Prefrontal Neuromodulation in Treatment-resistant Depression
|
N/A | |
Recruiting |
NCT05842291 -
pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression
|
N/A | |
Recruiting |
NCT04821271 -
Antidepressant Effects of TS-161 in Treatment-Resistant Depression
|
Phase 2 | |
Active, not recruiting |
NCT04670081 -
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
|
Phase 2 | |
Terminated |
NCT01598324 -
Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder
|
N/A | |
Recruiting |
NCT05710237 -
Does Psilocybin Require Psychedelic Effects to Treat Depression?
|
Phase 2 | |
Completed |
NCT03329391 -
Psychosocial Characteristics and Non-pharmacological Intervention of Patients With Treatment-resistant Depression
|
N/A |